Good At

1. Differentiation of small pulmonary nodules/ground-glass nodules from benign and malignant and timing of surgical intervention. 2. Bilateral/multiple small nodules precision surgery and pulmonary function preservation strategy 3. Minimally invasive surgery for early lung cancer, anatomical lung segment/lobe resection. Complex surgery for advanced lung cancer, tracheal carina reconstruction and vessel replacement. 4. Minimally invasive sleeve resection and airway reconstruction of intraairway tumors. 5. Targeted treatment and drug-resistant post-treatment of lung cancer, immunotherapy. Post-treatment of advanced lung cancer with multiple drug resistance.

Introduction

Wu Ning, male, associate chief physician, MD. Graduated from Fudan University School of Medicine in 2009. From 2020/February to 2020/April, as the sixth batch of medical team members from Shanghai City assisting Hubei, he went to the Guanggu District Intensive Care Unit of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology in Wuhan to participate in the rescue of critically ill patients with new coronavirus lung cancer. Through ECMO and other equipment, many critically ill patients were successfully treated. His areas of expertise are the differentiation of small pulmonary nodules/ground-glass nodules from benign and malignant, the formulation of follow-up plans and the timing of surgical intervention. Minimally invasive treatment of pulmonary nodules, minimally invasive anatomical lung segment resection. Targeted/immune/chemoradiotherapy combined treatment of advanced lung cancer, as well as post-drug resistant treatment of lung cancer and clinical new drug research.